Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. | 28,000 | reported | 29 May 2025 | tx 11+317,862−29,931 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 May 2025 | GRANT_AWARD | ADIAL PHARMACEUTICALS, INC. | 28,000 | 0.00 USD | deriv |
| 25 Mar 2024 | GRANT_AWARD | ADIAL PHARMACEUTICALS, INC. | 12,000 | 0.00 USD | deriv |
| 23 May 2023 | GRANT_AWARD | ADIAL PHARMACEUTICALS, INC. | 50,000 | 0.00 USD | deriv |
| 23 Feb 2022 | GRANT_AWARD | ADIAL PHARMACEUTICALS, INC. | 40,000 | 0.00 USD | deriv |
| 08 Feb 2021 | GRANT_AWARD | ADIAL PHARMACEUTICALS, INC. | 40,000 | 0.00 USD | deriv |
| 03 Mar 2020 | GRANT_AWARD | ADIAL PHARMACEUTICALS, INC. | 60,000 | 0.00 USD | deriv |
| 31 Jul 2018 | PURCHASE | ADIAL PHARMACEUTICALS, INC. | 14,000 | — | |
| 31 Jul 2018 | CONVERSION | ADIAL PHARMACEUTICALS, INC. | 29,931 | — | |
| 31 Jul 2018 | CONVERSION | ADIAL PHARMACEUTICALS, INC. | 29,931 | — | deriv |
| 31 Jul 2018 | CONVERSION | ADIAL PHARMACEUTICALS, INC. | 29,931 | — | deriv |
| 31 Jul 2018 | PURCHASE | ADIAL PHARMACEUTICALS, INC. | 14,000 | — | deriv |